posted on
Dec 02, 2007 07:39AM

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Message: Re: CAUTIOUS
2
Nov 30, 2007 10:50AM
2
Nov 30, 2007 11:01AM
1
Nov 30, 2007 12:52PM
Nov 30, 2007 01:27PM
4
Dec 01, 2007 08:54AM
Good points plyd.
But it will pleasantly surprise me if PTSC can match, much less exceed, the settlement revenue in the succeeding few quarters after the settlement.
This is why I’ve said that it is very important for Alliacense to totally understand their licensing bottleneck issues and resolve all their capacity issues before settlement. The revenue in the quarters after a settlement could make a huge difference in how PTSC is perceived – a fast growing company, or a one shot flash in the pan followed by mediocre earnings. This perception and PPS will then impact their ability to build or aquire additional revenue streams.
By the way, I think Alliancese has shown some signs of making improvements to their licensing systems and capacity – the hiring they’ve done may be an indication.
2 Recommendations
Loading...
Loading...
1
Dec 02, 2007 08:20AM
1
Dec 02, 2007 08:22AM
New Message
Please
login
to post a reply